December 2015: CTI grant approved
Together with the Adolphe Merkle Institute (AMI), InnoMedica has filed an application for research funding in the amount of CHF 350,000 at the Commission for Technology and Innovation (CTI) of the Swiss Confederation to support a three-year research project. The application (18641.1 PFNM-NM) was approved in its entirety on 30 December 2015. The AMI is an independent center of excellence at the University of Freiburg with a focus on research in the field of so-called soft nanomaterials. Innovation and industrial application are hereby their main goal. The cooperation in the project Structure-Behavior Relationships of Targeted Liposomal Drug Delivery Systems with our scientific partner is thus secured. As industrial partner, InnoMedica will benefit from further analytical investigations regarding liposomal targeting of the product Talidox and thereby expand the joint work with the AMI.